Royal Bank of Canada »

Verve Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-06-30 $180k 16k 11.53
2025-03-31 $362k 79k 4.57
2024-12-31 $451k 80k 5.64
2024-09-30 $164k 37k 4.48
2024-06-30 $50k 11k 4.75
2024-03-31 $235k 18k 13.30
2023-12-31 $132k 14k 9.80
2023-09-30 $263k 20k 13.24
2023-06-30 $321k 17k 18.77
2022-12-31 $244k 13k 19.49
2022-09-30 $251k 7.3k 34.38
2021-06-30 $428k 7.1k 60.28